Top Canadian Marijuana Stocks of 2017

This report highlights the Ubika Marijuana Index’s four top Canadian marijuana stocks during 2017 based on performance

SmallCapPower | December 22, 2017: With 2017 coming to an end, we look back at four of the Ubika Marijuana Index’s top performing stocks. The marijuana industry had a strong year of returns, with the sector raising more than $2 billion during the year, as companies continued to add capacity to serve the coming recreational market. The top Canadian marijuana stocks on our list from our Ubika Marijuana 20 Index have average YTD returns of 243%.

Read our previous Canadian marijuana sector reports >>

Emerald Health Therapeutics Inc. (TSXV:EMH) – $4.92

Emerald Health Therapeutics is developing production capacity and recently announced a 50/50 joint venture (called Pure Sunfarms) with Village Botanicals for the establishment of a large-scale production facility. Under the agreement, Village provided a 1.1 million square foot greenhouse facility (previously used for tomato cultivation), which will be retrofitted for the cultivation of cannabis. The company estimates that the initial facility could yield more than 75,000 KG of dried cannabis. The Company also has options to purchase an additional 3.7 million square feet of greenhouse space adjacent to the current facility being built.

  • Market Cap: $497 Million
  • YTD Total Return: 278.5%
  • 90 Day Return: 313.4%

Tetra Bio Pharma Inc. (TSXV:TBP) – $0.94

Tetra Bio Pharma develops cannabinoid-based biopharmaceutical products. The Company has applied for a license to produce medical marijuana under the Access to Cannabis for Medical Purposes Regulation and is undergoing trials for its medical marijuana products.

  • Market Cap: $110 Million
  • YTD Total Return: 241.8%
  • 90 Day Return: 54.1%

Cronos Group Inc. (TSXV:MJN) – $4.82

Cronos Group owns and operates two licensed producers of medical marijuana in Canada: Peace Naturals (medical) and In The Zone (recreational). The Company also actively seeks investment opportunities in companies that are licensed under Access to Cannabis for Medical Purposes Regulations or that are actively seeking a license. Cronos plans to ramp up production at its Peace Naturals facility from the existing 5,000 KG to 40,000 KG before 2019. Furthermore, the Company formed partnership with Israeli entity Gan Shmuel to set up a low-cost production facility in Israel. The proposed facility is expected to produce 24,000 KG.

  • Market Cap: $720 Million
  • YTD Total Return: 225.7%
  • 90 Day Return: 99.2%

CannTrust Holdings Inc. (CSE:TRST) – $8.10

Publicly listed in August 2017, CannTrust is a licensed producer of medical cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulation. CannTrust produces dried medical marijuana and oils at two facilities in Canada. The Company’s products are sold online and delivered to registered patients. CannTrust’s original 50,000 square foot production facility located in Vaughan, Ontario, uses hydroponic technology to produce at an annual capacity of 3,600 KG. Furthermore, CannTrust has set aside a 46-acre property, where it plans to add capacity with a 430,000-square foot expansion.

  • Market Cap: $740 Million
  • YTD Total Return: 224.0%
  • 90 Day Return: 170.0%­

Disclosure: Neither the author nor any of the principals at SmallCapPower, or their family members, own units in any of the companies mentioned above.

To read our full disclosure, please click on the button below: